The CNPEM is accredited to two major co-financing mechanisms for RD&I projects with companies, which allows greater sharing of innovation risks and the realization of more challenging projects. The Center has been accredited as an Embrapii Unit since 2014, in the Biotechnology area, and recently also became accredited to receive EMBRAPII and BNDES resources, which expands the benefits for companies, particularly startups. In addition, the Center is accredited to SIBRATEC Nano, which also generates major benefits for financing CNPEM’s projects with startups and small companies in the nanotechnology field.
Co-funding of RD&I projects with the CNPEM
Embrapii
The EMBRAPII CNPEM Biotechnology Unit promotes innovative research and development projects with companies of all sizes. Accredited by Embrapii, this unit uses non-reimbursable financial resources to share the risks associated with innovation and speed up the contracting process. Funding is available on a continuous basis without the need for calls for proposals.
The EMBRAPII CNPEM Biotechnology Unit is also qualified to contract projects under the Embrapii/BNDES partnership, through the INOVA+ Digital and Sustainable Industry Program. Explore the opportunities and strengthen innovation in biotechnology with CNPEM. Visit the Embrapii CNPEM Biotechnology Unit website to find out more.
SibratecNano
CNPEM, through the National Nanotechnology Laboratory (LNNano), is accredited to the SibratecNano network, a strategic articulation and financing mechanism that facilitates the co-development of projects between companies of different sizes and accredited laboratories. This accreditation allows CNPEM to work in the network’s two main areas: Nanomaterials & Nanocomposites and Nanodevices & Nanosensors.
Contact us
inovacao@cnpem.br
19 3512-1174